Addressing the Ongoing Plasma / Ig Shortage
Since late 2018, the Immune Deficiency Foundation (IDF) has been tracking a troubling shortage of plasma-based immunoglobulin (Ig) products, which are lifesaving, lifelong treatments for people with primary immunodeficiencies (PI), specifically those who are antibody deficient. We continue to monitor the situation day-to-day and week-to-week and offer guidance and input where we can to make a difference.
Treatment Info for Insurers & Payers
With appropriate treatment, many people with primary immunodeficiencies (PI) can live healthy productive lives and payers save by avoiding the costs of expensive resources including hospital care, tests and procedures. In order to best manage therapies, payers need resources and education surrounding PI treatment.
IDF seeks to educate and work collaboratively with payers to ensure that patients receive appropriate treatment and have access to the therapies they require. Click below to view a collection of resources and educational information surrounding the treatment of primary immunodeficiencies.